Assessing Axsome Therapeutics (AXSM) Valuation After Analyst Upgrades And Pipeline Progress [Yahoo! Finance]
Axsome Therapeutics, Inc. (AXSM)
Last axsome therapeutics, inc. earnings: 3/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
axsome.com
Company Research
Source: Yahoo! Finance
Axsome Therapeutics (AXSM) is back in focus after several analysts raised their ratings and outlooks, pointing to stronger commercial prospects and regulatory progress as key reasons for the recent move in the stock. See our latest analysis for Axsome Therapeutics. The latest analyst upgrades and regulatory milestones come on top of a 21.27% 1 month share price return and a 44.33% 3 month share price return, while the 1 year total shareholder return of 79.98% suggests momentum has been building rather than fading. If Axsome's recent moves have you looking across the sector, it could be a good moment to scan other healthcare stocks that might fit a similar high-growth, higher-risk profile. With Axsome now trading around US$186.98 and analyst targets clustered higher, plus an implied intrinsic discount, the key question is whether the recent surge still leaves room for upside or if the market is already pricing in future growth. Axsome Therapeutics' most followed valuation na
Show less
Read more
Impact Snapshot
Event Time:
AXSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXSM alerts
High impacting Axsome Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AXSM
News
- Axsome Therapeutics (NASDAQ:AXSM) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- Axsome Therapeutics (NASDAQ:AXSM) had its price target raised by analysts at Leerink Partners from $150.00 to $205.00. They now have an "outperform" rating on the stock.MarketBeat
- Top Picks 2026- Dynex Capital Inc. DX [Yahoo! Finance]Yahoo! Finance
- Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23GlobeNewswire
- Axsome Therapeutics: A Conditional Buy Built On SG&A Discipline [Seeking Alpha]Seeking Alpha
AXSM
Earnings
- 11/3/25 - Miss
AXSM
Sec Filings
- 1/23/26 - Form 4
- 1/23/26 - Form 4
- 1/22/26 - Form 144
- AXSM's page on the SEC website